Niagen Bioscience Statistics
Total Valuation
NAGE has a market cap or net worth of $164.28 million. The enterprise value is $97.00 million.
| Market Cap | 164.28M |
| Enterprise Value | 97.00M |
Important Dates
The last earnings date was Wednesday, November 4, 2026, after market close.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NAGE has 79.36 million shares outstanding. The number of shares has decreased by -1.42% in one year.
| Current Share Class | 79.36M |
| Shares Outstanding | 79.36M |
| Shares Change (YoY) | -1.42% |
| Shares Change (QoQ) | -4.07% |
| Owned by Insiders (%) | 25.00% |
| Owned by Institutions (%) | 44.69% |
| Float | 59.15M |
Valuation Ratios
The trailing PE ratio is 17.17 and the forward PE ratio is 34.97.
| PE Ratio | 17.17 |
| Forward PE | 34.97 |
| PS Ratio | 1.34 |
| Forward PS | 1.19 |
| PB Ratio | 1.97 |
| P/TBV Ratio | 2.11 |
| P/FCF Ratio | 35.88 |
| P/OCF Ratio | 33.65 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.11, with an EV/FCF ratio of 21.18.
| EV / Earnings | 9.47 |
| EV / Sales | 0.79 |
| EV / EBITDA | 25.11 |
| EV / EBIT | 34.74 |
| EV / FCF | 21.18 |
Financial Position
The company has a current ratio of 5.93, with a Debt / Equity ratio of 0.03.
| Current Ratio | 5.93 |
| Quick Ratio | 4.51 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.39 |
| Debt / FCF | 0.45 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 13.32% and return on invested capital (ROIC) is 15.19%.
| Return on Equity (ROE) | 13.32% |
| Return on Assets (ROA) | 1.69% |
| Return on Invested Capital (ROIC) | 15.19% |
| Return on Capital Employed (ROCE) | 3.04% |
| Weighted Average Cost of Capital (WACC) | 15.52% |
| Revenue Per Employee | $1.05M |
| Profits Per Employee | $87,521 |
| Employee Count | 117 |
| Asset Turnover | 1.18 |
| Inventory Turnover | 2.25 |
Taxes
In the past 12 months, NAGE has paid $815,000 in taxes.
| Income Tax | 815,000 |
| Effective Tax Rate | 7.37% |
Stock Price Statistics
The stock price has decreased by -69.91% in the last 52 weeks. The beta is 2.08, so NAGE's price volatility has been higher than the market average.
| Beta (5Y) | 2.08 |
| 52-Week Price Change | -69.91% |
| 50-Day Moving Average | 2.76 |
| 200-Day Moving Average | 3.82 |
| Relative Strength Index (RSI) | 29.89 |
| Average Volume (20 Days) | 555,057 |
Short Selling Information
The latest short interest is 4.18 million, so 5.26% of the outstanding shares have been sold short.
| Short Interest | 4.18M |
| Short Previous Month | 3.87M |
| Short % of Shares Out | 5.26% |
| Short % of Float | 7.06% |
| Short Ratio (days to cover) | 7.73 |
Income Statement
In the last 12 months, NAGE had revenue of $122.29 million and earned $10.24 million in profits. Earnings per share was $0.12.
| Revenue | 122.29M |
| Gross Profit | 78.10M |
| Operating Income | 2.79M |
| Pretax Income | 11.06M |
| Net Income | 10.24M |
| EBITDA | 3.86M |
| EBIT | 2.79M |
| Earnings Per Share (EPS) | $0.12 |
Balance Sheet
The company has $69.36 million in cash and $2.08 million in debt, with a net cash position of $67.28 million or $0.85 per share.
| Cash & Cash Equivalents | 69.36M |
| Total Debt | 2.08M |
| Net Cash | 67.28M |
| Net Cash Per Share | $0.85 |
| Equity (Book Value) | 83.07M |
| Book Value Per Share | 1.05 |
| Working Capital | 83.31M |
Cash Flow
In the last 12 months, operating cash flow was $4.88 million and capital expenditures -$303,000, giving a free cash flow of $4.58 million.
| Operating Cash Flow | 4.88M |
| Capital Expenditures | -303,000 |
| Depreciation & Amortization | 1.07M |
| Net Borrowing | -2,000 |
| Free Cash Flow | 4.58M |
| FCF Per Share | $0.06 |
Margins
Gross margin is 63.86%, with operating and profit margins of 2.28% and 8.37%.
| Gross Margin | 63.86% |
| Operating Margin | 2.28% |
| Pretax Margin | 9.04% |
| Profit Margin | 8.37% |
| EBITDA Margin | 3.16% |
| EBIT Margin | 2.28% |
| FCF Margin | 3.74% |
Dividends & Yields
NAGE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.42% |
| Shareholder Yield | 1.42% |
| Earnings Yield | 5.83% |
| FCF Yield | 2.79% |
Analyst Forecast
The average price target for NAGE is $11.75, which is 467.63% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.75 |
| Price Target Difference | 467.63% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 9.44% |
| EPS Growth Forecast (3Y) | -28.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
The last stock split was on April 13, 2016. It was a reverse split with a ratio of 1:3.
| Last Split Date | Apr 13, 2016 |
| Split Type | Reverse |
| Split Ratio | 1:3 |
Scores
NAGE has an Altman Z-Score of 9.26 and a Piotroski F-Score of 4.
| Altman Z-Score | 9.26 |
| Piotroski F-Score | 4 |